206010021703 Indifference Diseases 0.000 claims description 20.230000000875 corresponding Effects 0.000 claims description 79.230000014509 gene expression Effects 0.000 claims description 83.230000004044 response Effects 0.000 claims abstract description 22.

Assignors: GRADOVITCH, NOAH, PERRY, MORDECHAL, SAYEGH, ROBERT, GOLANY, BOAZ, SHACHNAI, HADAS, SHMUELI, ODED, YEHEZKEL, BENNY Publication of US20040133526A1 publication Critical patent/US20040133526A1/en Status Abandoned legal-status Critical Current Links ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US27695201P priority Critical Priority to US27942201P priority Priority to US28700401P priority Priority to US30507301P priority Priority to US32729101P priority Priority to PCT/US2002/008293 priority patent/WO2002077759A2/en Application filed by Dealigence Inc filed Critical Dealigence Inc Priority to US10/663,858 priority patent/US20040133526A1/en Assigned to DEALIGENCE INC.

Original Assignee Dealigence Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Abandoned Application number US10/663,858 Inventor Oded Shmueli Boaz Golany Robert Sayegh Hadas Shachnai Mordechai Perry Noah Gradovitch Benny Yehezkel Current Assignee (The listed assignees may be inaccurate.

Toad for oracle versions